Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-25-002867
Filing Date
2025-08-04
Accepted
2025-08-04 16:29:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9535
  Complete submission text file 0001172661-25-002867.txt   11322
Mailing Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130
Business Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130 857-343-8292
ImageneBio, Inc. (Subject) CIK: 0001835579 (see all company filings)

EIN.: 811697316 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92449 | Film No.: 251180761
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 2034090812
Deep Track Capital, LP (Filed by) CIK: 0001856083 (see all company filings)

EIN.: 853360885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A